These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38290229)

  • 1. Synergistic activity of clioquinol with voriconazole and amphotericin B against fungi of interest in eye infections.
    Reginatto P; Agostinetto GJ; Teixeira ML; de Andrade SF; Fuentefria AM
    J Mycol Med; 2024 Mar; 34(1):101462. PubMed ID: 38290229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
    Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against
    Rees CA; Bao R; Zegans ME; Cramer RA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
    Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
    Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Ozdemir HG; Oz Y; Ilkit M; Kiraz N
    Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation.
    Martin-Vicente A; Guarro J; Capilla J
    Int J Antimicrob Agents; 2017 Apr; 49(4):422-426. PubMed ID: 28257903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
    Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
    [No Abstract]   [Full Text] [Related]  

  • 9. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
    Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
    Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O; Dugar J; Miller D; OʼBrien TP
    Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
    Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
    Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
    Taj-Aldeen SJ; Salah H; Al-Hatmi AM; Hamed M; Theelen B; van Diepeningen AD; Boekhout T; Lass-Flörl C
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical Fusarium isolates.
    de Chaves MA; Ferreira do Amaral T; Monteiro da Silva Rodrigues Coutinho N; Fernanda Andrzejewski Kaminski T; Teixeira ML; Flavio Souza de Oliveira L; de Andrade SF; Fuentefria AM
    Mycoses; 2020 Oct; 63(10):1069-1082. PubMed ID: 32662568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
    Chaturvedi V; Ramani R; Andes D; Diekema DJ; Pfaller MA; Ghannoum MA; Knapp C; Lockhart SR; Ostrosky-Zeichner L; Walsh TJ; Marchillo K; Messer S; Welshenbaugh AR; Bastulli C; Iqbal N; Paetznick VL; Rodriguez J; Sein T
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1543-8. PubMed ID: 21282457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
    Mukherjee PK; Chandra J; Yu C; Sun Y; Pearlman E; Ghannoum MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4450-7. PubMed ID: 22669723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
    Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
    JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
    Martinez PS; Whitley RD; Plummer CE; Richardson RL; Hamor RE; Wellehan JFX
    Vet Ophthalmol; 2022 Sep; 25(5):376-384. PubMed ID: 35684950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.